Edgewise Therapeutics (EWTX) Enterprise Value (QoQ) (2020 - 2026)
Edgewise Therapeutics (EWTX) Enterprise Value (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Edgewise Therapeutics | 4.21 Bn | 4.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.69% |
| Dec 31, 2025 | 89.14% |
| Sep 30, 2025 | -1,197.81% |
| Jun 30, 2025 | 13.05% |
| Mar 31, 2025 | -19.81% |
| Dec 31, 2024 | 91.54% |
| Sep 30, 2024 | -1,032.57% |
| Jun 30, 2024 | 91.84% |
| Mar 31, 2024 | -518.84% |
| Dec 31, 2023 | -161.24% |
| Sep 30, 2023 | -3.62% |
| Jun 30, 2023 | 34.05% |
| Mar 31, 2023 | -119.30% |
| Dec 31, 2022 | 79.96% |
| Sep 30, 2022 | 55.82% |
| Jun 30, 2022 | -620.98% |
| Mar 31, 2022 | -121.33% |
| Dec 31, 2021 | 94.64% |
| Sep 30, 2021 | 2.91% |
| Jun 30, 2021 | -35.36% |